Related Experiment Video

Updated: Mar 15, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

1.0K

Pioglitazone inhibits EGFR/MDM2 signaling-mediated PPARγ degradation

Juanjuan Shi1, Wenbo Zhang2, Mengli You3

  • 1Department of Oncology, The Affiliated Wujin Hospital, Jiangsu University, Changzhou, Jiangsu, People's Republic of China; Institute of Life Science, Jiangsu University, Zhenjiang, Jiangsu Province, People's Republic of China.

European Journal of Pharmacology
|September 11, 2016
PubMed

Insights

Pioglitazone reverses cancer cell chemoresistance by inhibiting epidermal growth factor receptor (EGFR) and MDM2-mediated degradation of peroxisome proliferator-activated receptor γ (PPARγ). This offers a new cancer treatment strategy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Aberrant activation of epidermal growth factor receptor (EGFR) signaling drives cancer progression.
  • Peroxisome proliferator-activated receptor γ (PPARγ) normally inhibits inflammation and cancer, but is degraded via EGFR/MDM2 signaling in cancer cells.
  • Understanding EGFR/MDM2-mediated PPARγ regulation is crucial for developing novel cancer therapies.

Purpose of the Study:

  • To investigate the mechanism by which EGFR signaling affects PPARγ protein levels in cancer cells.
  • To evaluate the effect of the PPARγ agonist pioglitazone on EGFR-induced PPARγ degradation.
  • To determine if pioglitazone can overcome chemoresistance mediated by EGFR/MDM2 signaling.

Main Methods:

  • Cancer cell culture and stimulation with epidermal growth factor (EGF).
  • Analysis of PPARγ protein levels, phosphorylation, and ubiquitination.
  • Treatment with PPARγ agonist pioglitazone and chemotherapy drugs.
  • Assessment of cancer cell sensitivity to chemotherapy.

Main Results:

  • EGF stimulation reduced PPARγ protein levels in cancer cells through phosphorylation, ubiquitination, and degradation.
  • Pioglitazone treatment reversed EGF-induced PPARγ degradation.
  • Pioglitazone significantly increased cancer cell sensitivity to chemotherapy drugs.

Conclusions:

  • Pioglitazone inhibits EGFR/MDM2-mediated cancer cell chemoresistance by stabilizing PPARγ.
  • This study reveals a novel mechanism for overcoming chemoresistance.
  • Pioglitazone represents a potential therapeutic strategy for enhancing cancer treatment efficacy.
Keywords:
DegradationEGFRPPARγPioglitazoneUbiquitination

More Related Videos

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

14.7K
Isolation and Differentiation of Stromal Vascular Cells to Beige/Brite Cells07:22

Isolation and Differentiation of Stromal Vascular Cells to Beige/Brite Cells

Published on: March 28, 2013

39.6K

Related Concept Videos

Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
860
Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
796
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
1.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Oral Hypoglycemic Agents: Glinides01:06

Oral Hypoglycemic Agents: Glinides

Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
804
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
16.8K